Trial Profile
Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 13 Sep 2014 Interim results (n = 17) presented at the 30th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
- 01 Nov 2012 Planned initiation date changed from 1 Mar 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov record.
- 13 Mar 2012 New trial record